COVID-19 associated cognitive impairment: A systematic review
- PMID: 35537236
- PMCID: PMC9014565
- DOI: 10.1016/j.cortex.2022.04.006
COVID-19 associated cognitive impairment: A systematic review
Abstract
Introduction: COVID-19 has a wide range of clinical manifestations. Neurological manifestations in COVID-19 patients were demonstrated during the pandemic, including cognitive impairment. This study aimed to determine any relationship between COVID-19 and cognitive complaints, such as dementia, mild cognitive impairment (MCI), or subjective cognitive decline (SCD).
Methods: We performed a systematic review of MEDLINE via Ebsco, Cochrane EMBASE, SCOPUS, and LILACS electronic databases of observational studies with COVID-19 patients confirmed by serology or PCR who developed new cognitive impairment or deteriorated from previous cognitive impairment after infection. This review protocol was recorded on PROSPERO with registration number CRD 42021241590.
Results: A total of 3.520 articles were retrieved and read. Twenty-two studies were selected for our review. A wide range of cognitive assessment tools (n = 25) was used. The most described affected domains in these studies were executive functions, attention, and episodic memory. Thirteen studies showed a pattern of cognitive impairment in processing speed, inattention, or executive dysfunction assessed through working memory.
Conclusion: This review highlights the high frequency of cognitive impairment after COVID-19 infection. However, we were unable to differentiate whether the cognitive impairment found corresponded to mild cognitive impairment or dementia through data from selected studies, and this issue serves as one objective of future studies to be addressed on this topic.
Keywords: COVID-19; Cognitive impairment; Dementia; Risk factor; SARS-CoV-2 infection.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest One of the authors (Pedro Braga Neto) received funding from the Brazilian National Council for Scientific and Technological Development (CNPq) as research grant funding and from the Brazilian Funding Grant Number 88881.505364/2020-01 from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES). José Wagner Leonel Tavares Júnior, Ana Célia Caetano de Souza, José Wicto Pereira Borges, Danilo Nunes Oliveira, José Ibiapina Siqueira Neto, Manoel Alves Sobreira Neto declare that they have no conflict of interest.
Figures


Similar articles
-
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159. Cochrane Database Syst Rev. 2001. PMID: 11687175 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Measures implemented in the school setting to contain the COVID-19 pandemic.Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029. Cochrane Database Syst Rev. 2022. Update in: Cochrane Database Syst Rev. 2024 May 2;5:CD015029. doi: 10.1002/14651858.CD015029.pub2. PMID: 35037252 Free PMC article. Updated.
-
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.Cochrane Database Syst Rev. 2022 Jun 16;6(6):CD012558. doi: 10.1002/14651858.CD012558.pub2. Cochrane Database Syst Rev. 2022. PMID: 35709018 Free PMC article.
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article.
Cited by
-
The Coronavirus Footprint on Dual-Task Performance in Post-Acute Patients after Severe COVID-19: A Future Challenge for Rehabilitation.Int J Environ Res Public Health. 2022 Aug 26;19(17):10644. doi: 10.3390/ijerph191710644. Int J Environ Res Public Health. 2022. PMID: 36078366 Free PMC article.
-
Investigation of Neuropsychological Dysfunction Among Recovered Nurses: The COVID-19.Cureus. 2024 Apr 24;16(4):e58929. doi: 10.7759/cureus.58929. eCollection 2024 Apr. Cureus. 2024. PMID: 38800204 Free PMC article.
-
Cognitive and other neuropsychiatric symptoms in COVID-19: analysis of person-generated longitudinal health data from a community-based registry.BMJ Open. 2023 Jun 19;13(6):e069118. doi: 10.1136/bmjopen-2022-069118. BMJ Open. 2023. PMID: 37336535 Free PMC article.
-
Cognitive impairment in post-acute COVID-19 syndrome: a scoping review.Arq Neuropsiquiatr. 2023 Dec;81(12):1053-1069. doi: 10.1055/s-0043-1777115. Epub 2023 Dec 29. Arq Neuropsiquiatr. 2023. PMID: 38157873 Free PMC article.
-
Long COVID in Brain Health Research: A Call to Action.Brain Sci. 2024 Jun 8;14(6):587. doi: 10.3390/brainsci14060587. Brain Sci. 2024. PMID: 38928587 Free PMC article. Review.
References
-
- Araújo W.C.O. Recuperação da informação em saúde: Construção, modelos e estratégias. Convergências em Ciência da Informação. 2020;3(2):100–134. doi: 10.33467/conci.v3i2.13447. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous